Incannex Secures US Patent for OSA Treatment
Incannex Healthcare Inc. announced the USPTO has granted a patent covering its proprietary oral therapy IHL-42X for obstructive sleep apnea. This intellectual property milestone strengthens the commercial value of the asset and supports its long-term strategic development.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day